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Introduction
Endovascular treatment of carotid artery stenosis is
potentially an attractive alternative to carotid endar-
terectomy in the prevention of stroke. Even with
the use of distal protection devices, however, there
remains a risk of distal embolisation, thought to be
the main culprit for the shortfalls of carotid angio-
plasty and stenting.
Evidence from the coronary circulation has sug-
gested a strong relationship between the morphology
of the atherosclerotic plaque and complications from
endovascular procedures; plaque disruption, yellow
colour and thrombus overlying the plaques seen
with coronary angioscopy are all associated with early
adverse outcomes such as myocardial infarction or the
need for re-intervention after coronary angioplasty.1
Within saphenous vein grafts, angiographic features
associated with distal embolisation (measured by a
rise in CK levels) include diffuse disease, ulceration,
overlying thrombus, a large plaque volume and eccen-
tricity of the plaque.2
This review discusses the relationship between the
morphological structure of carotid atherosclerotic pla-
ques and the potential for embolisation during endo-
vascular procedures, to explore how the structure of
the atherosclerotic plaque can be used to determine
the risk of embolisation and cerebral complications
during angioplasty and stenting. Methods to prevent
embolisation are also discussed.
Morphology and Spontaneous Embolisation
The morphology of the atherosclerotic plaque
is thought to be one of the most important factors in
determining its stability. Histological examination of
plaques has shown that morphological features such
as plaque surface fissuring or ulceration,3±6 fibrous
cap thinning,3 luminal thrombus,5 haemorrhage with-
in the plaque,7±9 and an increased volume of the lipid
core10 are all associated with symptomatic disease.
Spontaneous asymptomatic embolisation can be
detected using transcranial Doppler (TCD) monitor-
ing of the ipsilateral middle cerebral artery (MCA).
Increased numbers of pre-operative cerebral microem-
boli are detected distal to plaques subsequently found
to be ulcerated and associated with luminal throm-
bosis during post-operative histological examination.5
In vivo carotid plaque morphology can be analysed
using a number of modalities. Duplex is the most
widely used tool. Echolucent plaques, shown to be
soft with a rich lipid component containing haemor-
rhage,11,12 are associated with clinically symptomatic
disease13±18 and greater numbers of subcortical and
cortical infarcts on computerised tomographic (CT)
imaging19,20 when compared with echogenic plaques.
Echolucent plaques have also been directly associated
with emboli in the ipsilateral MCA using TCD.21
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Ultrasound based computer assisted plaque analysis
again confirms echolucent plaques are more prone to
symptoms but in addition, has studied the cap and
surface disruption using duplex. The absence of a
visible cap and plaque surface defects are significantly
associated with symptomatic disease.22
A new tool in the investigation of the morphological
features of the carotid plaque is magnetic resonance
imaging. This has been shown to identify specific
plaque features such as the fibrous cap, ulceration
and fissuring23 as well as lipid, fibrous, calcified, heam-
orrhagic and thrombotic components.24 Using MRI
the presence of major plaque surface irregularities
has been shown to correlate with symptomatic
disease.25
Embolisation during Endoluminal
Procedures
Although morphology of the carotid plaque is closely
related to increased numbers of symptomatic and
asymptomatic emboli prior to intervention the rela-
tionship between morphology and emboli during
endoluminal interventions is less clear.
Ex vivo models of carotid stenting provide a useful
method of studying emboli directly. A study of 5
plaques examined embolisation during angioplasty26
and showed that emboli are produced at all stages
of the angioplasty procedure, but were significantly
greater in size after the balloon dilatation stage.
Two plaques examined in this study had an irregu-
lar, ulcerated surface on pre-operative angiograms.
These plaques showed substantially greater numbers
and larger sizes of emboli. Ohki27 performed carotid
artery stenting in a model on 24 circumferentially
intact plaques. Multivariate analysis demonstrated
that echolucent plaques and plaques with stenoses of
greater than 90% were independently associated with
a significantly greater number of emboli during
carotid stenting. The echolucent nature of highly
embolising plaques suggests a role for morphology
in determining those patients at high risk during
angioplasty.
Another model used to study this subject has used
human carotid arteries in situ in cadavers.28 In 19
arteries from 10 cadavers, the presence of intraplaque
haemorrhage on post angioplasty histology was sig-
nificantly associated with increased numbers of lipid
filled foam cells in emboli. These authors showed no
association between percentage stenosis or echogeni-
city and embolisation, but the diameter of all stenoses
was less than 90% (range 32±85%) and only 4 of 19
were echolucent in character.
In vivo evidence for the relationship between
morphology and embolisation during endoluminal
intervention is limited by the accuracy of carotid pla-
que imaging. Using angiography only long or mul-
tiple stenoses are associated with periprocedural
neurological events.29,30 The presence of ulceration,
irregularity, high-grade stenosis and extension into
the common carotid bifurcation had no effect on out-
come during these studies.
With a primary interest in exploring the use of
Duplex examination of plaque structure, the ICAROS
Registry (Imaging in Carotid Angioplasties and Risk
Of Stroke) has been set up to further examine the
role of imaging of the carotid plaque and determine
which patients can safely undergo carotid endolum-
inal intervention.31 This has now been presented in
abstract form.32 Three hundred and eighty seven
patients undergoing carotid artery stenting were stu-
died with an overall cerebral complication rate of
6.2%. Analysis of Duplex information showed that 19
of 24 plaques giving rise to cerebral complications had
a GSM of less than 25 (indicating very soft plaques).
This finding suggests that duplex plaque characterisa-
tion may have a strong role in predicting those at high
risk of complications during carotid stenting.
The use of cerebral protection systems during
endovascular procedures has allowed collection of
potential emboli. Blood samples obtained after stent
deployment in the pooled blood below an inflated
protection balloon show large numbers of cholesterol
crystals and lipoid masses33±35 and examination of dis-
tal protection device filters has shown predominantly
thrombotic material, foam cells and cholesterol
masses36 implying that the lipid core and overlying
thrombus are potent sources of embolisation. Angio-
plasty within other circulations shows similar
results.37
Potential Methods for Further Study of
Morphology and Embolic Potential
The occurrence of emboli during carotid endovascular
procedures may be detected using TCD and has clearly
documented embolic signals occurring during the vast
majority of interventional procedures that are per-
formed, mostly without obvious neurological seque-
lae.38±40 Emboli occur during all stages of the
procedure with significant numbers of emboli being
produced during guide wire insertion,39 when the
cerebral circulation is not protected. Twenty-two per
cent of patients undergoing angioplasty or angio-
plasty and stenting have new lesions on MRI follow-
ing intervention.41 To our knowledge none have
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studied how emboli number or new infarcts are
related to the morphology of the atherosclerotic pla-
que using these methods. These non-invasive meth-
ods are useful to detect emboli and their consequences
within the cerebral circulation at the time of endolum-
inal therapy and may be used to further study the
relationship between the morphology of the athero-
sclerotic plaque and embolic potential.
More accurate methods of identifying the specific
morphology of the plaque may lead to a better under-
standing of whether plaque characteristics may be
used to determine those at increased risk during
angioplasty or stenting. MRI of atherosclerotic plaque
structure has the potential to determine specific mor-
phological features associated with embolisation and
symptoms.
Emboli can be directly visualised in the retinal ves-
sels after carotid endoluminal intervention.42 Using
distal protection devices in a series of 118 patients,
retinal embolisation could be seen in 6 patients,
although only those with emboli greater than 20 mm
in size caused symptoms. This method could be used
to directly study the production of emboli from mor-
phologically different plaques.
Prevention of Embolisation
Modifications to the endoluminal procedure have
attempted to limit the number of emboli escaping
into the cerebral circulation. Primary stenting has
now replaced balloon angioplasty as the initial pro-
cedure in the carotid circulation as microemboli seem
to occur significantly less frequently during stenting
than balloon angioplasty.39,43 In addition, smaller
diameter, more flexible guidewires are employed to
prevent dislodging significant numbers of emboli dur-
ing their passage through the stenosis.
Distal protection devices employ mechanical meth-
ods to prevent embolic damage to the brain. There are
three methods commonly used. Devices employing a
filter distal to the balloon site snare large particles
destined to cause strokes. Balloons placed within the
ICA distal to the stenosis also prevent distal embolisa-
tion with emboli subsequently removed by aspiration
or flushing into the external carotid artery circulation.
Occlusion of the common carotid artery and external
carotid artery with reversal of the internal carotid
blood flow through an arteriovenous shunt avoids
direct cannulation of the ICA.
Evaluation of filters used as distal protection has
shown these methods to be technically feasible and
successful.34,36,44,45 The filters used in these trials trap
emboli, some over 5 mm in size, in 53±84% of filters.
When incorporated into an ex vivo model of carotid
artery angioplasty the NeuroSheild device (Mednova)
has been shown to capture 88% of particles within the
filter.46 Moreover, the maximum size of captured
emboli was substantially higher than those produced
during initial passage of the device and those missed
by the filter. Filters are now used widely in clinical
practice with low neurological complication rates,
which compare favourably to standard unprotected
methods.47
Balloon protection devices also prevent large
quantities of embolic material reaching the cerebral
circulation.33,35,48 In vitro evaluation of distal balloon
protection and aspiration of pooled blood shows that
98% of emboli may be removed using this technique.49
Distal balloon protection devices have been shown to
reduce the number of emboli produced when mea-
sured by TCD.50
Ohki51 has demonstrated the effectiveness of rever-
sal of flow in the ICA and distal CCA in an animal
model. Insertion and inflation of a balloon in the CCA
proximal to the lesion and the formation of an artificial
arterio-venous shunt into the femoral vein proved
effective in recovering all artificial embolic material
introduced into the CCA. This method of flow reversal
has been developed for clinical use, such as the Parodi
Anti-Embolism System44 and has been shown to be safe
and effective in early clinical trials.52 This method has
also been suggested simply as a mechanism to safely
deploy the distal filter without risk of embolisation.53
The use of distal protection devices, however, is not
without complication. With filter and balloon protec-
tion devices there remains a necessity to pass a guide
wire and device through a potentially unstable athero-
sclerotic plaque, which may dislodge particulate
matter. Not all significant particles are captured
using distal protection devices, new cerebral lesions
shown on MRI have been demonstrated in 3 of 20
carotid stenting patients,54 presumably from emboli
produced during passage of the distal protection
device or those that were missed. Moreover, there is
potential for embolisation via other routes such as the
external carotid pathway.42,55 TCD monitoring during
endovascular procedures with various distal protec-
tion devices44 has demonstrated embolic signals at all
stages of the procedure when using a filter in the ICA
and on crossing the lesion and balloon deflation with
the ICA balloon occlusion device.
Despite these problems, ex vivo analysis of embolic
material26 suggests that the mean and maximum size
of emboli produced during guide wire passage is
smaller than after balloon deflation.
In addition to the problems associated with embo-
lisation, the use of balloons to temporarily occlude
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flow within the ICA leads to a prolonged cerebral
ischaemic time, which may interfere with blood pres-
sure control.56
Conclusions
There is strong evidence that the morphology of
atherosclerotic plaque is important in the develop-
ment of spontaneous symptoms in the carotid and
coronary circulations but the relationship between
morphology, endovascular procedures and emboli is
less well understood.
Distal protection devices trap or divert many emboli
seen with this procedure and lead to a substantial fall
in the number of cerebral complications seen as a
result. However they do not prevent all emboli espe-
cially during placement of the distal filter or balloon
and the characteristics of the plaque must therefore
still be considered.
Plaques with an ulcerated cap and overlying throm-
bus and those with a large lipid core may be more
susceptible to distal embolisation and complications.
Duplex characterisation of carotid plaque morphology
has emerged as a useful technique in determining
the risk of cerebral complications during endoluminal
intervention and warrants continued investigation.
Further investigation of the role of morphology using
different methods of emboli detection may determine
the risks of endoluminal intervention within indi-
vidual patients according to plaque morphology.
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